- Home
- NOTV vs NRO Comparison
NOTV vs NRO Comparison
Compare NOTV & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- NRO
- Stock Information
- Founded
- NOTV 1974
- NRO 2003
- Country
- NOTV United States
- NRO United States
- Employees
- NOTV N/A
- NRO N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- NRO Finance/Investors Services
- Sector
- NOTV Health Care
- NRO Finance
- Exchange
- NOTV Nasdaq
- NRO Nasdaq
- Market Cap
- NOTV 137.5M
- NRO 156.7M
- IPO Year
- NOTV 1997
- NRO N/A
- Fundamental
- Price
- NOTV $2.71
- NRO $3.21
- Analyst Decision
- NOTV Strong Buy
- NRO
- Analyst Count
- NOTV 1
- NRO 0
- Target Price
- NOTV $5.00
- NRO N/A
- AVG Volume (30 Days)
- NOTV 595.3K
- NRO 239.4K
- Earning Date
- NOTV 05-07-2025
- NRO 01-01-0001
- Dividend Yield
- NOTV N/A
- NRO 11.41%
- EPS Growth
- NOTV N/A
- NRO N/A
- EPS
- NOTV N/A
- NRO N/A
- Revenue
- NOTV $480,402,000.00
- NRO N/A
- Revenue This Year
- NOTV $5.57
- NRO N/A
- Revenue Next Year
- NOTV $5.23
- NRO N/A
- P/E Ratio
- NOTV N/A
- NRO N/A
- Revenue Growth
- NOTV N/A
- NRO N/A
- 52 Week Low
- NOTV $1.15
- NRO $2.51
- 52 Week High
- NOTV $6.48
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- NOTV 60.76
- NRO 51.48
- Support Level
- NOTV $1.96
- NRO $3.16
- Resistance Level
- NOTV $2.96
- NRO $3.24
- Average True Range (ATR)
- NOTV 0.24
- NRO 0.06
- MACD
- NOTV 0.08
- NRO -0.00
- Stochastic Oscillator
- NOTV 75.00
- NRO 53.33
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").